Crystal structure of Aedes aegypti trypsin inhibitor in complex with μ-plasmin reveals role for scaffold stability in Kazal-type serine protease inhibitor.
Aedes aegypti trypsin inhibitor
Kazal-type protease inhibitor
plasmin
protein scaffold stability
surface loops of serine proteases
Journal
Protein science : a publication of the Protein Society
ISSN: 1469-896X
Titre abrégé: Protein Sci
Pays: United States
ID NLM: 9211750
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
11
11
2021
received:
11
08
2021
accepted:
12
11
2021
pubmed:
21
11
2021
medline:
22
3
2022
entrez:
20
11
2021
Statut:
ppublish
Résumé
Kazal-type protease inhibitor specificity is believed to be determined by sequence of the reactive-site loop that make most, if not all, contacts with the serine protease. Here, we determined the complex crystal structure of Aedes aegypti trypsin inhibitor (AaTI) with μ-plasmin, and compared its reactivities with other Kazal-type inhibitors, infestin-1 and infestin-4. We show that the shortened 99-loop of plasmin creates an S2 pocket, which is filled by phenylalanine at the P2 position of the reactive-site loop of infestin-4. In contrast, AaTI and infestin-1 retain a proline at P2, rendering the S2 pocket unfilled, which leads to lower plasmin inhibitions. Furthermore, the protein scaffold of AaTI is unstable, due to an elongated Cys-V to Cys-VI region leading to a less compact hydrophobic core. Chimeric study shows that the stability of the scaffold can be modified by swapping of this Cys-V to Cys-VI region between AaTI and infestin-4. The scaffold instability causes steric clashing of the bulky P2 residue, leading to significantly reduced inhibition of plasmin by AaTI or infestin-4 chimera. Our findings suggest that surface loops of protease and scaffold stability of Kazal-type inhibitor are both necessary for specific protease inhibition, in addition to reactive site loop sequence. PDB ID code: 7E50.
Identifiants
pubmed: 34800067
doi: 10.1002/pro.4245
pmc: PMC8820117
doi:
Substances chimiques
Serine Proteinase Inhibitors
0
Trypsin Inhibitors
0
Trypsin
EC 3.4.21.4
Fibrinolysin
EC 3.4.21.7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
470-484Informations de copyright
© 2021 The Protein Society.
Références
Biochimie. 2019 Nov;166:52-76
pubmed: 31505212
J Mol Biol. 2002 Apr 26;318(2):533-46
pubmed: 12051857
EMBO J. 1995 Nov 1;14(21):5149-57
pubmed: 7489704
FEBS Lett. 1996 Apr 29;385(1-2):81-6
pubmed: 8641473
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10316-21
pubmed: 12142461
iScience. 2019 Nov 22;21:564-576
pubmed: 31726374
FEBS Lett. 1995 Nov 13;375(1-2):15-7
pubmed: 7498466
Proteins. 2007 May 15;67(3):569-78
pubmed: 17348026
Biochimie. 2011 Mar;93(3):618-23
pubmed: 21167902
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
J Biol Chem. 1997 Aug 8;272(32):19931-7
pubmed: 9242660
Structure. 1999 Aug 15;7(8):989-96
pubmed: 10467148
Proteins. 2017 Mar;85(3):435-444
pubmed: 27936493
Structure. 1997 Nov 15;5(11):1465-74
pubmed: 9384562
Curr Opin Struct Biol. 2003 Feb;13(1):130-9
pubmed: 12581670
Chem Rev. 2002 Dec;102(12):4501-24
pubmed: 12475199
Proteins. 2013 Dec;81(12):2159-66
pubmed: 23996272
Biochemistry. 2005 Jul 19;44(28):9626-36
pubmed: 16008348
J Struct Biol. 2019 Jun 1;206(3):280-294
pubmed: 30930219
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1410-5
pubmed: 11171964
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Crit Rev Eukaryot Gene Expr. 1995;5(3-4):385-436
pubmed: 8834232
Biochem Biophys Res Commun. 1995 Jul 26;212(3):1115-24
pubmed: 7626100
Sci Adv. 2021 Feb 5;7(6):
pubmed: 33547079
Biol Chem. 2007 Nov;388(11):1183-94
pubmed: 17976011
Insect Biochem Mol Biol. 2002 Sep;32(9):991-7
pubmed: 12213235
FEBS Lett. 1994 Dec 5;355(3):290-6
pubmed: 7988692
Structure. 2018 Sep 4;26(9):1178-1186.e3
pubmed: 30017565
J Immunol. 2016 Feb 1;196(3):1218-26
pubmed: 26712948
J Am Chem Soc. 1948 Sep;70(9):3034-40
pubmed: 18882536
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
pubmed: 12393927
Phys Rev Lett. 2003 Feb 21;90(7):075503
pubmed: 12633242
PLoS One. 2013;8(1):e54104
pubmed: 23335990
FEBS J. 2012 Dec;279(24):4466-78
pubmed: 23075397
Biochem Soc Trans. 2019 Apr 30;47(2):541-557
pubmed: 30837322
Dev Comp Immunol. 2010 Apr;34(4):377-86
pubmed: 19995574
J Biomed Biotechnol. 2012;2012:482096
pubmed: 23118509
Acta Crystallogr F Struct Biol Commun. 2017 Aug 01;73(Pt 8):469-475
pubmed: 28777090
J Mol Biol. 2019 Feb 1;431(3):557-575
pubmed: 30543823
Protein Sci. 2022 Feb;31(2):470-484
pubmed: 34800067
Nat Protoc. 2017 Feb;12(2):255-278
pubmed: 28079879
PLoS Negl Trop Dis. 2018 May 10;12(5):e0006451
pubmed: 29746468
J Synchrotron Radiat. 2004 Jan 1;11(Pt 1):53-5
pubmed: 14646133
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Biochimie. 2010 Aug;92(8):933-9
pubmed: 20363282
Acta Crystallogr D Biol Crystallogr. 2012 Jun;68(Pt 6):695-702
pubmed: 22683792